Shenzhen YHLO Biotech Co., Ltd.

SHSE:688575 Rapport sur les actions

Capitalisation boursière : CN¥10.1b

Shenzhen YHLO Biotech Croissance future

Future contrôle des critères 5/6

Shenzhen YHLO Biotech is forecast to grow earnings and revenue by 39.8% and 25.7% per annum respectively. EPS is expected to grow by 39.8% per annum. Return on equity is forecast to be 18.4% in 3 years.

Informations clés

39.8%

Taux de croissance des bénéfices

39.8%

Taux de croissance du BPA

Medical Equipment croissance des bénéfices27.5%
Taux de croissance des recettes25.7%
Rendement futur des capitaux propres18.4%
Couverture par les analystes

Good

Dernière mise à jour03 Nov 2024

Mises à jour récentes de la croissance future

Pas de mise à jour

Recent updates

Estimating The Intrinsic Value Of Shenzhen YHLO Biotech Co., Ltd. (SHSE:688575)

Oct 31
Estimating The Intrinsic Value Of Shenzhen YHLO Biotech Co., Ltd. (SHSE:688575)

Shenzhen YHLO Biotech (SHSE:688575) Is Reinvesting At Lower Rates Of Return

Oct 12
Shenzhen YHLO Biotech (SHSE:688575) Is Reinvesting At Lower Rates Of Return

Shenzhen YHLO Biotech Co., Ltd.'s (SHSE:688575) Price In Tune With Earnings

Aug 30
Shenzhen YHLO Biotech Co., Ltd.'s (SHSE:688575) Price In Tune With Earnings

Does Shenzhen YHLO Biotech (SHSE:688575) Have A Healthy Balance Sheet?

Jul 18
Does Shenzhen YHLO Biotech (SHSE:688575) Have A Healthy Balance Sheet?

Shenzhen YHLO Biotech Co., Ltd. (SHSE:688575) Not Lagging Market On Growth Or Pricing

May 23
Shenzhen YHLO Biotech Co., Ltd. (SHSE:688575) Not Lagging Market On Growth Or Pricing

Shenzhen YHLO Biotech's (SHSE:688575) Sluggish Earnings Might Be Just The Beginning Of Its Problems

May 01
Shenzhen YHLO Biotech's (SHSE:688575) Sluggish Earnings Might Be Just The Beginning Of Its Problems

There Are Reasons To Feel Uneasy About Shenzhen YHLO Biotech's (SHSE:688575) Returns On Capital

Mar 19
There Are Reasons To Feel Uneasy About Shenzhen YHLO Biotech's (SHSE:688575) Returns On Capital

Prévisions de croissance des bénéfices et des revenus

SHSE:688575 - Estimations futures des analystes et données financières antérieures (CNY Millions )
DateRecettesLes revenusFlux de trésorerie disponibleCash from OpMoy. Nombre d'analystes
12/31/20263,443806N/A8174
12/31/20252,738611N/A6887
12/31/20242,171452N/A7057
9/30/20241,90228966735N/A
6/30/20241,938387-36613N/A
3/31/20241,824340-339359N/A
12/31/20232,053355-736-73N/A
9/30/20232,397424-333292N/A
6/30/20232,719488-214419N/A
3/31/20233,27158266663N/A
12/31/20223,9811,0121,0181,583N/A
9/30/20223,450923412933N/A
6/30/20222,967782381816N/A
3/31/20222,312678501813N/A
12/31/20211,178205-113260N/A
9/30/20211,147216-45253N/A
6/30/20211,118198-26230N/A
3/31/20211,020198-38230N/A
1/1/202199921193282N/A
12/31/2019877108-6068N/A
12/31/201872938-15730N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: 688575's forecast earnings growth (39.8% per year) is above the savings rate (2.9%).

Bénéfices vs marché: 688575's earnings (39.8% per year) are forecast to grow faster than the CN market (25.8% per year).

Croissance élevée des bénéfices: 688575's earnings are expected to grow significantly over the next 3 years.

Chiffre d'affaires vs marché: 688575's revenue (25.7% per year) is forecast to grow faster than the CN market (14% per year).

Croissance élevée des revenus: 688575's revenue (25.7% per year) is forecast to grow faster than 20% per year.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: 688575's Return on Equity is forecast to be low in 3 years time (18.4%).

Découvrir les entreprises en croissance

7D

1Y

7D

1Y

7D

1Y